Dengue Vaccine: What You Need to Know [2025]

Details

• Alternative Title:
  Dengue Vaccine: What You Need to Know [2025] [English] ; Vaccine Information Statement: Dengue Vaccine: What You Need to Know [2025]
• Corporate Authors:
  Centers for Disease Control and Prevention (U.S.)
• Description:
  A VIS or Vaccine Information Statement is a document, produced by CDC, that informs vaccine recipients – or their parents or legal representatives – about the benefits and risks of a vaccine they are receiving. All vaccine providers, public or private, are required by the National Vaccine Childhood Injury Act (NCVIA – 42 U.S.C. § 300aa-26) to give the appropriate VIS to the patient (or parent or legal representative) prior to every dose of specific vaccines. The appropriate VIS must be given prior to the vaccination, and must be given prior to each dose of a multi-dose series. It must be given regardless of the age of the recipient: from https://www.cdc.gov/vaccines/hcp/about-vis/index.html.
  
  VISs have been translated into about 40 languages. These can be found on the website of CDC's partner, https://www.immunize.org/vis/. Not every VIS has been translated into every language.
  
  Why get vaccinated? Dengue vaccine can help protect against dengue in people who have had dengue in the past. Dengue is caused by one of four viruses spread through the bite of an infected mosquito. A person can get infected by any of the four dengue viruses. Infection with one dengue virus does not protect against infection with the other three viruses. Each year, up to 400 million people are infected with dengue. Almost half of the world’s population lives in areas with a risk of dengue. Most people infected with dengue have no symptoms or experience mild disease. Some people who get sick with dengue have sudden onset of fever with nausea, vomiting, a rash, and eye, muscle, joint, or bone aches and pains. A smaller number of people with dengue will have severe diseases. Severe dengue is a medical emergency, requiring immediate medical attention at a hospital. Hospitalization with dengue is most common in older children and adolescents. Warning signs of severe dengue begin 12 to 24 hours after fever goes away and include stomach pain and tenderness, vomiting, bleeding from the nose or gums, blood in vomit or stool, and extreme tiredness or restlessness. Rarely, dengue can have serious effects on the liver, heart, central nervous system, kidneys, eyes, muscles, or bone marrow. Severe dengue can also lead to death.
  
  
• Subjects:
  Dengue Dengue / Prevention & Control Dengue Vaccines Dengue Vaccines / Adverse Effects Dengue Virus Severe Dengue Severe Dengue / Complications Vaccines
• Series:
  Vaccine Information Statement
• Subseries:
  Dengue Vaccine
• Publisher:
  Centers for Disease Control and Prevention (CDC) (U.S.)
• Document Type:
  Text
• Genre:
  Fact Sheet ; Patient Education Handout
• Place as Subject:
  United States
• Rights:
  Public Domain
• Topic:
  Diseases & Conditions
• Location:
  North America
• Pages in Document:
  2 pdf pages
• Collection(s):
  Infectious Diseases
• Main Document Checksum:
  urn:sha-512:e63e550f9bccf3f3d93d5f964edae3e41c14fc103c259a71dab6b17ede81f145b610185d7672d8c82f21563bcadb5fc5329834342b697a87c267bcadf0d368d6
• Download URL:
  https://stacks.cdc.gov/view/cdc/253469/cdc_253469_DS1.pdf
• File Type:
  [PDF - 180.12 KB ]